Title | Journal | Journal Categories | Citations | Publication Date |
---|---|---|---|---|
Rofecoxib Increases Susceptibility of Human LDL and Membrane Lipids to Oxidative Damage: A Mechanism of Cardiotoxicity | Journal of Cardiovascular Pharmacology |
| 57 | 2006 |
Nonsteroidal anti-inflammatory drugs and the heart | Circulation |
| 2014 | |
GI-REASONS: A Novel 6-Month, Prospective, Randomized, Open-Label, Blinded Endpoint (PROBE) Trial | American Journal of Gastroenterology |
| 42 | 2013 |
Cardiovascular safety of lumiracoxib: a meta-analysis of randomised controlled trials in patients with osteoarthritis | European Journal of Clinical Pharmacology |
| 10 | 2013 |
Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications | 2013 |